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Abstract
Stimulus-induced perturbations from the steady state are a hallmark of signal transduction. In some signaling modules, the
steady state is characterized by rapid synthesis and degradation of signaling proteins. Conspicuous among these are the
p53 tumor suppressor, its negative regulator Mdm2, and the negative feedback regulator of NFkB, IkBa. We investigated
the physiological importance of this turnover, or flux, using a computational method that allows flux to be systematically
altered independently of the steady state protein abundances. Applying our method to a prototypical signaling module, we
show that flux can precisely control the dynamic response to perturbation. Next, we applied our method to experimentally
validated models of p53 and NFkB signaling. We find that high p53 flux is required for oscillations in response to a
saturating dose of ionizing radiation (IR). In contrast, high flux of Mdm2 is not required for oscillations but preserves p53
sensitivity to sub-saturating doses of IR. In the NFkB system, degradation of NFkB-bound IkB by the IkB kinase (IKK) is
required for activation in response to TNF, while high IKK-independent degradation prevents spurious activation in
response to metabolic stress or low doses of TNF. Our work identifies flux pairs with opposing functional effects as a
signaling motif that controls the stimulus-sensitivity of the p53 and NFkB stress-response pathways, and may constitute a
general design principle in signaling pathways.
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Introduction
Eukaryotic cells must constantly recycle their proteomes. Of the
approximately 109 proteins in a typical mouse L929 fibrosarcoma
cell, 106 are degraded every minute [1]. Assuming first-order
degradation kinetics, this rate of constitutive protein turnover, or
flux, imposes an average half-life of 24 hours. Not all proteins are
equally stable, however. Genome-wide quantifications of protein
turnover in HeLa cells [2,3] and 3T3 murine fibroblasts [4] show
that protein half-lives can span several orders of magnitude. Thus
while some proteins exist for months and even years [5], others are
degraded within minutes. Gene ontology terms describing
signaling functions are highly enriched among short-lived proteins
[3,6,7], suggesting that rapid turnover is required for proper signal
transduction. Indeed, defects in protein turnover are implicated in
the pathogenesis of cancer and other types of human disease [8,9].
Conspicuous among short-lived signaling proteins are those that
regulate the p53 and NFkB stress response pathways. The p53
protein itself, for example, has a half-life of less than 30 minutes
[10,11]. Mdm2, the E3 ubiquitin ligase responsible for regulating
p53, has a half-life of 45 minutes [4]. And the half-life of unbound
IkBa, the negative feedback regulator of NFkB, is less than
15 minutes [12,13] (see Figure S1), requiring that 6,500 new
copies of IkBa be synthesized every minute [13]. Given the
energetic costs of protein synthesis, we hypothesized that rapid
turnover of these proteins is critical to the stimulus-response
behavior of their associated pathways.
To test our hypothesis we developed a method to systematically
alter the rates of protein turnover in mass action models without
affecting their steady state abundances. Our method requires an
analytical expression for the steady state of a model, which we
derive using the py-substitution method described in a companion
manuscript. From this expression, changes in parameter values
that do not affect the steady state are found in the null space of the
matrix whose elements are the partial derivatives of the species
abundances with respect to the parameters. We call this vector
space the isostatic subspace. After deriving a basis for this subspace,
linear combinations of basis vectors identify isostatic perturbations
that modify specific reactions independently of all the others, for
example those that control protein turnover. By systematic
application of these isostatic perturbations to a model operating
at steady state, the effects of flux on stimulus-responsiveness can be
studied in isolation of changes to steady-state abundances (see
Methods).
We first apply our method to a prototypical negative feedback
module in which an activator controls the expression of its own
negative regulator. We show that reducing the flux of either the
activator or its inhibitor slows the response to stimulation.
However, reducing the flux of the activator lowers the magnitude
of the response, whereas reducing the flux of the inhibitor
PLOS Computational Biology | www.ploscompbiol.org 1 February 2013 | Volume 9 | Issue 2 | e1002932
increases it. This complementarity allows the activator and
inhibitor fluxes to exert precise control over the module’s response
to stimulation.
Given this level of control, we hypothesized that rapid turnover
of p53 and Mdm2 must be required for p53 signaling. A hallmark
of p53 is that it responds to DNA damage in a series of digital
pulses [14–18]. These pulses are important for determining cell
fate [19–21]. To test whether high p53 and Mdm2 flux are
required for p53 pulses, we applied our method to a model in
which exposure to ionizing radiation (IR) results in oscillations of
active p53 [17]. By varying each flux over three orders of
magnitude, we show that high p53 flux is indeed required for
oscillations. In contrast, high Mdm2 flux is not required, but
rather controls the refractory time in response to transient
stimulation. If the flux of Mdm2 is low, a second stimulus after
22 hours does not result in appreciable activation of p53.
In contrast to p53, the flux of NFkB turnover is very low, while
the flux of its inhibitor, IkB, is very high. Prior to stimulation, most
NFkB is sequestered in the cytoplasm by IkB. Upon stimulation by
an inflammatory signal like tumor necrosis factor alpha (TNF),
IkB is phosphorylated and degraded, resulting in rapid but
transient translocation of NFkB to the nucleus and activation of its
target genes [22–24]. Two separate pathways are responsible for
the turnover of IkB [12]. In one, IkB bound to NFkB is
phosphorylated by the IkB kinase (IKK) and targeted for
degradation by the ubiquitin-proteasome system. In the other
pathway, unbound IkB is targeted for degradation and requires
neither IKK nor ubiquitination [25,26]. We call these the
‘‘productive’’ and ‘‘futile’’ fluxes, respectively. Applying our
method to a model of NFkB activation, we show that the futile
flux acts as a negative regulator of NFkB activation while the
productive flux acts as a positive regulator. We find that turnover
of bound IkB is required for NFkB activation in response to TNF,
while high turnover of unbound IkB prevents spurious activation
of NFkB in response to low doses of TNF or ribotoxic stress caused
by ultraviolet light (UV). As with p53 then, juxtaposition of a
positive and negative regulatory flux govern the sensitivity of
NFkB to different stimuli, and may constitute a common signaling
motif for controlling stimulus-specificity in diverse signaling
pathways.
Results
Activator and inhibitor fluxes can precisely control the
dynamics of signaling
To examine the effects of flux on stimulus-responsiveness, we
built a prototypical negative feedback model reminiscent of the
p53 or NFkB stress-response pathways (Figure 1A). In it, an
activator ‘‘X’’ is constitutively expressed but catalytically degraded
by an inhibitor, ‘‘Y’’. The inhibitor is constitutively degraded but
its synthesis requires X. Activation is achieved by instantaneous
depletion of Y, the result of which is accumulation of X until
negative feedback forces a return to steady state. The dynamics of
this response can be described by two values: A, the amplitude or
maximum value of X after stimulation, and T , the time at which A
is observed (Figure 1B). Parameters for this model were chosen
such that the abundances of both X and Y are one arbitrary unit
and X achieves its maximum value of A~10 a:u: at time T~24,
where the units of time are also arbitrary.
Figure 1. A prototypical negative feedback module. (A) In this
simple model of negative feedback control, an activator X is
constitutively produced but catalytically degraded by an inhibitor, Y.
Y is constitutively degraded but its synthesis requires X. Each of these
four reactions is modeled using mass action kinetics. To stimulate the
model and activate X, the steady-state abundance of Y is instanta-
neously depleted. (B) In response to stimulation, the abundance of X
increases until activator-induced synthesis of Y forces a return to
steady-state. This response can be characterized by A, the maximum
abundance of X following stimulation, and T , the time at which A is
observed. Parameters were chosen for this model such that the steady
state abundances of X and Y equal one arbitrary unit and the stimulus-
induced amplitude of X is 10 a:u: at time T~24. The rates of activator
synthesis (C), inhibitor synthesis (D), activator degradation (E), and
inhibitor degradation (F) were multiplied by 10{1 (gray) to 10z1 (blue)
prior to stimulation as described above. For each multiplier, the
dynamics of the activator response are plotted on the right. Similar
plots were generated by multiplying the flux of the activator (G), and
the flux of the inhibitor (H), as described in Methods.
doi:10.1371/journal.pcbi.1002932.g001
Author Summary
Eukaryotic cells constantly synthesize new proteins and
degrade old ones. While most proteins are degraded
within 24 hours of being synthesized, some proteins are
short-lived and exist for only minutes. Using mathematical
models, we asked how rapid turnover, or flux, of signaling
proteins might regulate the activation of two well-known
transcription factors, p53 and NFkB. p53 is a cell cycle
regulator that is activated in response to DNA damage, for
example, due to ionizing radiation. NFkB is a regulator of
immunity and responds to inflammatory signals like the
macrophage-secreted cytokine, TNF. Both p53 and NFkB
are controlled by at least one flux whose effect on
activation is positive and one whose effect is negative. For
p53 these are the turnover of p53 and Mdm2, respectively.
For NFkB they are the TNF-dependent and -independent
turnover of the NFkB inhibitor, IkB. We find that
juxtaposition of a positive and negative flux allows for
precise tuning of the sensitivity of these transcription
factors to different environmental signals. Our results
therefore suggest that rapid synthesis and degradation of
signaling proteins, though energetically wasteful, may be a
common mechanism by which eukaryotic cells regulate
their sensitivity to environmental stimuli.
Protein Turnover Controls Stimulus-Sensitivity
PLOS Computational Biology | www.ploscompbiol.org 2 February 2013 | Volume 9 | Issue 2 | e1002932
To address the role of these parameters in shaping the response
of the activator, we first performed a traditional sensitivity analysis.
We found that increasing the synthesis of X (Figure 1C), or
decreasing the degradation of X (Figure 1D) or the synthesis of Y
(Figure 1E), all result in increased responsiveness. However, these
changes also increase the abundance of X. To distinguish between
the effects caused by changes in flux and those caused by changes
in abundance, we developed a method that alters the flux of X and
Y while maintaining their steady state abundances at 1 a:u:. Using
this method, we found that increasing the flux of X increases
responsiveness (Figure 1G), but not to the same extent as
increasing the synthesis parameter alone (Figure 1C). In contrast,
reducing the flux of Y yields the same increase in responsiveness as
decreasing the synthesis of Y (Figure 1E) or the degradation of X
(Figure 1D). These observations suggest that both the flux and
abundance of X are important regulators of the response, as is the
flux of Y, but not its abundance. This conclusion is supported by
the observation that when the abundance of Y is increased by
reducing its degradation, there is little effect on signaling
(Figure 1F).
To further characterize the effects of flux on the activator’s
response to stimulation, we applied systematic changes to the
fluxes of X and Y prior to stimulation and plotted the resulting
values of A and T . Multiplying the flux of X over the interval
10{1,10z1
 
showed, as expected, that the value of A increases
while the value of T deceases (Figure 2A). In other words, a high
activator flux results in a strong, fast response to stimulation. If we
repeat the process with the inhibitor, we find that both A and T
decrease as the flux increases; a high inhibitor flux results in a fast
but weak response (Figure 2B). This result illustrates that fluxes of
different regulators can have different but complementary effects
on stimulus-induced signaling dynamics.
Complementarity suggests that changes in flux can be identified
such that A is altered independently of T , or T independently of
A. Indeed, if both activator and inhibitor fluxes are increased in
equal measure, A is held fixed while the value of T decreases
(Figure 2C). Increasing both fluxes thus simultaneously reduces the
timescale of the response without affecting its magnitude. An
equivalent relationship can be found such that T remains fixed
while A is affected (Figure 2D). Because an increase in either flux
will reduce T , to alter A without affecting T requires an increase
in one flux but a decrease in the other. Also, T is more sensitive to
changes in the inhibitor flux versus the activator flux; small changes
in the former must be paired with larger changes in the latter. This
capability to achieve any value of A or T indicates that flux can
precisely control the response to stimulation, without requiring any
changes to steady state protein abundance.
High p53 and Mdm2 flux is required for p53
responsiveness to ionizing radiation
Given that flux precisely controls the dynamic response to
stimulation in a prototypical signaling module, we hypothesized
that for p53, oscillations in response to DNA damage require the
high rates of turnover reported for p53 and Mdm2. To test this, we
applied our method to a published model of p53 activation in
response to ionizing gamma radiation (IR), a common DNA
damaging agent (Figure 3A) [17]. Because the model uses arbitrary
units, we rescaled it so that the steady state abundances of p53 and
Mdm2, as well as their rates of synthesis and degradation, matched
published values (see Table S1). We note that these values are also
in good agreement with the consensus parameters reported in
[16].
Next we implemented a multiplier of Mdm2-independent p53
flux and let it take values on the interval 10{2,10z1
 
. For each
value we simulated the response to IR using a step function in the
production of the upstream Signal molecule, k11, as previously
described [17]. To characterize the p53 response we let A? be the
amplitude of stable oscillations in phosphorylated p53 (Figure 3B),
and use this as a metric for p53 sensitivity. Where A?w0, we say
the module is sensitive to IR stimulation. We find that A? is
greater than zero only when the flux of p53 is near its observed
value or higher (Figure 4A). If the flux of p53 is reduced by 2-fold
or more, p53 no longer stably oscillates in response to stimulation,
but exhibits damped oscillations instead.
Interestingly, repeating this analysis with a multiplier for the
Mdm2 flux over the same interval reveals that Mdm2 flux has little
bearing on p53 oscillations (Figure 4B). For any value of the
multiplier chosen, A?w0. As with p53, this multiplier alters the
Signal-independent flux of Mdm2 but does not affect Signal-
induced Mdm2 degradation. If oscillations are already compro-
mised by a reduced p53 flux, no concomitant reduction in Mdm2
flux can rescue the oscillations (Figure 4C). We therefore conclude
that the flux of p53, but not Mdm2, is required for IR-sensitivity in
the p53 signaling module. What then is the physiological relevance
of high Mdm2 flux? In the model, signal-mediated Mdm2 auto-
ubiquitination [27] is a major contributor to Mdm2 degradation
after stimulation. If Signal production is transient, Mdm2 protein
levels must be restored solely via Signal-independent degradation.
We therefore hypothesized that if the flux of Mdm2 is low, Mdm2
protein levels would remain elevated after stimulation and
compromise sensitivity to subsequent stimuli.
To test this hypothesis we again let the Mdm2 flux multiplier
take values over the interval 10{2,10z1
 
. For each value we
stimulated the model with a 2-hour pulse of Signal production,
followed by 22 hours of rest, followed by a second 2-hour pulse
(Figure 3B). We defined A1 to be the amplitude of the first peak of
phosphorylated p53 and A2 to be the amplitude of the second
peak. Sensitivity to the second pulse is defined as the difference
between A1 and A2, with A1{A2~0 indicating full sensitivity. As
seen in Figures 4D and E, the flux of p53 has no bearing on the
sensitivity to the second pulse while the flux of Mdm2 strongly
affects it. At one one-hundredth the observed Mdm2 flux –
corresponding to protein half-life of 3-days – over 20,000 fewer
molecules of p53 are phosphorylated, representing more than a
two-fold reduction in sensitivity (Figure 4E). This result is robust
with respect to the interval of time chosen between pulses (Figure
S2). If the sensitivity to the second pulse is already compromised
by a reduced Mdm2 flux, a concomitant reduction in p53 flux fails
to rescue it, while an increase in p53 flux still further reduces it
(Figure 4F). We therefore conclude that the flux of Mdm2, and not
p53, controls the system’s refractory time, and a high Mdm2 flux is
required to re-establish sensitivity after transient stimulation.
High IkB flux buffers NFkB from activation in response to
UV and low doses of TNF
A second major stress-response pathway is that of NFkB. NFkB
is potently induced by the inflammatory cytokine TNF, but shows
a remarkable resistance to internal metabolic perturbations or
ribotoxic stresses induced by ultraviolet light (UV) [13], or to
triggers of the unfolded protein response (UPR) [28]. Like p53, the
dynamics of NFkB activation play a major role in determining
target gene expression programs [29,30]. Although NFkB is
considered stable, the flux of IkBa – the major feedback regulator
of NFkB – is conspicuously high. We hypothesized that turnover
of IkB controls the stimulus-responsiveness of the NFkB signaling
module.
Beginning with a published model of NFkB activation [13], we
removed the beta and epsilon isoforms of IkB, leaving only the
Protein Turnover Controls Stimulus-Sensitivity
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predominant isoform, IkBa (hereafter, simply ‘‘IkB’’; Figure 5A).
Steady state analysis of this model supported the observation that
almost all IkB is degraded by either of two pathways: a ‘‘futile’’
flux, in which IkB is synthesized and degraded as an unbound
monomer; and a ‘‘productive’’ flux, in which free IkB enters the
nucleus and binds to NFkB, shuttles to the cytoplasm, then binds
to and is targeted for degradation by IKK (Figure 5B). These two
pathways account for 92.5% and 7.3% of the total IkB flux,
respectively. The inflammatory stimulus TNF was modeled as
before, using a numerically-defined IKK activity profile derived
from in vitro kinase assays [30] (Figure 5A, variable T ). Stimulating
with TNF results in strong but transient activation of NFkB. A
second stimulus, ribotoxic stress induced by UV irradiation, was
modeled as 50% reduction in translation and results in only
modest activity [13]. As above, we let AT be the amplitude of
activated NFkB in response to TNF and TT the time at which AT
is observed. Analogously, we let AU be the amplitude of NFkB in
response to UV, and TU the time at which NFkB activation equals
one-half AU (see Figure 5C). We then implemented multipliers for
the futile and productive flux and let each multiplier take values on
the interval 10{2,10z1
 
. For each value we simulated the NFkB
response to TNF and UV and plotted the effects on A and T .
The results show that reducing the productive flux yields a
slower, weaker response to TNF (Figure 6A). By analogy to
Figure 2, this indicates that the productive flux of IkB is a
positive regulator of NFkB activation. In contrast, the futile flux
acts as a negative regulator of NFkB activity, though its effects
on AT and TT are more modest (Figure 6B). Thus, similar to
p53, the activation of NFkB is controlled by a positive and
negative regulatory flux. In response to UV, a reduction in
either flux delays NFkB activation, but reducing the futile flux
results in a significant increase in AU while reducing the
productive flux has almost no effect (Figure 6C and D).
Conversely, while an increase in the futile flux has no effect
on AU , an increase in the productive flux results in a significant
increase. If we now define NFkB to be sensitive to TNF or UV
when AT or AU are ten-fold higher than its active but pre-
stimulated steady state abundance, then TNF sensitivity requires
a productive flux multiplier w10{1:6, while UV insensitivity
requires a productive flux multiplier v100:7 and a futile flux
multiplier w10{0:8. This suggests that the flux pathways of IkB
may be optimized to preserve NFkB sensitivity to external
inflammatory stimuli while minimizing sensitivity to internal
metabolic stresses.
Figure 2. Effects of flux on the dynamic response to stimulation. (A) The magnitude of the activator flux is varied between 10{1 (light gray)
and 10z1 (dark gray) times its nominal steady-state value prior to stimulation. The peak amplitude A of X in response to stimulation is observed to
increase with the flux of X while the time T at which the peak occurs is observed to decrease. Representative profiles of the activator at low, wildtype,
and high values of the flux are shown at right. The dashed red line indicates the nominal wildtype response. (B) The magnitude of the inhibitor flux is
varied between 10{1 and 10z1 times its nominal steady-state value prior to stimulation. Both A and T are observed to decrease. (C) The fluxes of
both X and Y are varied simultaneously between 10{1 and 10z1 times their nominal wildtype values. As a result, A is held constant while T is
reduced. (D) The magnitude of the inhibitor flux is varied between 10{1 and 10z1 times its nominal steady-state value prior to stimulation. For each
value of this flux, the value of activator flux is calculated such that T is held constant. As in row 2 above, A is observed to decrease as the magnitude
of the flux of Y increases.
doi:10.1371/journal.pcbi.1002932.g002
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In contrast to p53, the negative regulatory flux of IkB dominates
the positive flux. We hypothesized that this imbalance must affect
the sensitivity of NFkB to weak stimuli. To test this hypothesis we
generated dose-response curves for TNF and UV using the
following multipliers for the futile flux: 10{2, 10{1, 100, and 10z1
(see Methods). The results confirm that reducing the futile flux of
IkB results in hypersensitivity at low doses of TNF (Figure 7, Row
1). At one one-hundredth the wildtype flux, a ten-fold weaker TNF
stimulus yields an equivalent NFkB response to the full TNF
stimulus at the wildtype flux. Similarly, a high futile flux prevents
strong activation of NFkB in response to UV (Figure 7, Row 2). At
10{1 and 10{2 times the futile flux, UV stimulation results in a
20-fold increase in NFkB activity, compared to just a 2-fold
increase at the wildtype flux. We therefore conclude that turnover
of unbound IkB controls the EC50 of the NFkB signaling module,
and that rapid turnover renders NFkB resistant to metabolic and
spurious inflammatory stimuli.
Discussion
Previous studies have shown that the fluxes of p53 [10,11], its
inhibitor Mdm2 [31,32], and the unbound negative regulator of
NFkB, IkB [12], are remarkably high. To investigate whether
rapid turnover of these proteins is required for the stimulus-
response behavior of the p53 and NFkB stress response pathways,
we developed a computational method to alter protein turnover,
or flux, independently of steady state protein abundance.
For p53, we show that high flux is required for sensitivity to
sustained stimulation after ionizing radiation (Figure 4A). Inter-
estingly, inactivating mutations in p53 have long been known to
enhance its stability [33], either by interfering with Mdm2-
catalyzed p53 ubiquitination [34,35], or by affecting p53’s ability
to bind DNA and induce the expression of new Mdm2 [36–39].
Inactivation of p53 also compromises the cell’s sensitivity to IR
[40,41–43]. Our results offer an intriguing explanation for this
phenomenon, that p53 instability is required for oscillations in
response to IR. Indeed, IR sensitivity was shown to correlate with
p53 mRNA abundance [44–46], a likely determinant of p53
protein flux. In further support of this hypothesis, mouse
embryonic fibroblasts lacking the insulin-like growth factor 1
receptor (IGF-1R) exhibit reduced p53 synthesis and degradation,
but normal protein abundance. These cells were also shown to be
insensitive to DNA damage, caused by the chemotherapeutic
agent etoposide [32].
Like p53, increased stability of Mdm2 has been observed in
human leukemic cell lines [47], and Mdm2 is a strong determinant
of IR sensitivity [48,49]. Again our results suggest these
observations may be related. Activation of p53 in response to IR
is mediated by the ATM kinase (‘‘Signal’’ in Figure 3) [50,51].
Batchelor et al. show that saturating doses of IR result in feedback-
driven pulses of ATM, and therefore p53 [17]. In Figure 4B we
show that these are independent of Mdm2 flux. However, sub-
saturating doses of IR (10 Gy versus 0.5 Gy) [52,53] cause only
transient activation of ATM [54], after which constitutive Mdm2
synthesis is required to restore p53 sensitivity (Figure 4E). This
suggests that high Mdm2 flux is required for sensitivity to
prolonged exposure to sub-saturating doses of IR. Indeed, this
inverse relationship between flux and refractory time has been
observed before. In Ba/F3 pro-B cells, high turnover of the Epo
receptor maintains a linear, non-refractory response over a broad
range of ligand concentrations [55].
For NFkB, our method revealed that an isostatic reduction in
the half-life of IkB sensitizes NFkB to TNF (Figure 7A), as well as
to ribotoxic stress agents like UV (Figure 7B). This observation
agrees with previous theoretical studies using a dual kinase motif,
where differential stability in the effector isoforms can modulate
the dynamic range of the response [56]. For NFkB, the flux of free
IkB acts as a kinetic buffer against weak or spurious stimuli, similar
to serial post-translational modifications on the T cell receptor
[57], or complementary kinase-phosphatase activities in bacterial
two-component systems [58]. In contrast, increasing the half-life of
IkBa alone – without a coordinated increase in its rate of synthesis
– increases the abundance of free IkBa and actually dampens the
activity of NFkB in response to TNF [25]. This difference
highlights the distinction between isostatic perturbations and
traditional, unbalanced perturbations that also affect the steady
state abundances. It also calls attention to a potential hazard when
trying to correlate stimulus-responsiveness with protein abundance
measurements: observed associations between responses and
protein abundances do not rule out implied changes in kinetic
parameters as the causal link. Indeed static, and not kinetic
measurements, are the current basis for molecular diagnosis of
clinical specimens. Thus while nuclear expression of p53 [59–66]
and NFkB [67–69] have been shown to correlate with resistance to
treatment in human cancer, the correlation is not infallible [40,70–
74]. If stimulus-responsiveness can be controlled by protein
turnover independently of changes to steady state abundance,
then correlations between abundance and a therapeutic response
may be masked by isostatic heterogeneity between cells.
For p53 and NFkB, we show that stimulus sensitivity can be
controlled by a paired positive and negative regulatory flux. We
propose that this pairing may constitute a common regulatory
motif in cell signaling. In contrast to other regulatory motifs
[75,76], the ‘‘flux motif’’ described here does not have a unique
structure. The positive p53 flux, for example, is formed by the
synthesis and degradation of p53 itself, while the positive flux in
Figure 3. A model of p53 oscillations in response to ionizing
radiation. (A) The model shown here is structurally identical to [17],
but parameter values have been scaled to match published rates of
synthesis and degradation for p53 and Mdm2 as well as their steady-
state abundances (see Methods). (B) Ionizing radiation is modeled as an
increase in synthesis of the Signal molecule (left; model parameter k11)
[17]. In response to a step increase in Signal production, phosphory-
lated p53 is observed to oscillate. We define A? to be the amplitude of
the stable oscillations. In response to a 2-hour pulse in Signal
production (right), p53 exhibits a transient peak in phosphorylation,
as does Mdm2. We define A1 to be the amplitude of phosphorylated
p53, and A2 to be its amplitude in response to a second, identical pulse,
22 hours after the first pulse.
doi:10.1371/journal.pcbi.1002932.g003
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the NFkB system includes the nuclear import of free NFkB and
export of NFkB bound to IkB. For p53, the negative flux is formed
by synthesis and degradation of Mdm2, while for NFkB it is
formed by the synthesis, shuttling, and degradation of cytoplasmic
and nuclear IkB. Thus the reaction structure for each flux is quite
different, but they nevertheless form a regulatory motif that is
Figure 4. Effects of flux on the p53 response to ionizing radiation. (A) The Mdm2-independent flux of p53 is varied between 10{2 and 10z1
times its wildtype value prior to a step increase in Signal production (model parameter k11; light gray to dark gray) [17]. The magnitude of A? is
plotted as a function of this p53 flux multiplier. Values that give rise to stable oscillations are shaded in blue. At right, representative profiles of
phosphorylated p53 are shown for high, wildtype, moderate, and low values of the multiplier. Note that the wildtype flux is indicated by the dashed
line in red. (B) As row 1, above, but now the p53-independent flux of Mdm2 is varied between 10{2 and 10z1 times its wildtype value (light gray to
dark gray). Stable oscillations are observed for all values of the Mdm2 flux multiplier. (C) As row 2, above, but for all simulations the flux of p53 is at
one-tenth its nominal wildtype value. Instead of sustained oscillations, damped oscillations are observed for all values of the Mdm2 flux multiplier. (D)
The flux of p53 is varied between 10{2 and 10z1 times its wildtype value prior to a 2-hour pulse in Signal production, followed by 22 hours of rest,
followed by a second 2-hour pulse. No difference is observed in the amplitude of phosphorylated p53 in response to the first and second pulse. (E) As
row 4, above, but now the flux of Mdm2 is varied instead of p53. At lower values of the Mdm2 flux multiplier, a significant difference is observed
between the amplitude of phosphorylated p53 in response to the first and second pulse. (F) As row 4, above, but while the p53 flux is allowed to vary,
the flux of Mdm2 is held constant at 10{1:5 times its wildtype value. This concomitant reduction of the p53 flux is not able to rescue the Mdm2-
compromised response to the second pulse.
doi:10.1371/journal.pcbi.1002932.g004
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common to both pathways (Figure 8). And since the mathematical
models used here are only abstractions of the underlying network,
the true structure of the p53 and NFkB flux motifs are in reality
even more complex.
The identification of a flux motif that controls stimulus-
responsiveness independently of protein abundances may prompt
experimental investigation into the role of flux in signaling. At a
minimum, this could be achieved using fluorescently-labeled
activator and inhibitor proteins in conjunction with tunable
synthesis and degradation mechanisms. The tet-responsive pro-
moter system [77,78], for example, could provide tunable
synthesis, while the CLP-XP system [79] could provide tunable
degradation. For the two-dimensional analysis presented here, and
to avoid confounding effects on signaling dynamics caused by
shared synthesis and degradation machinery [80], independently
tunable synthesis and degradation mechanisms may be required. If
these techniques are applied to mutants lacking the endogenous
regulators, this would further allow decreases in protein flux to be
studied in addition to strictly increases.
Finally, in this study we have examined the effects of flux on
stimulus-responsiveness, but in a typical signaling module, many
other isostatic perturbations exist. For example, the isostatic
subspace of our NFkB model has 18 dimensions, of which only a
few were required by the analysis presented here. By simultaneously
Figure 5. A model of IkB-regulated NFkB activation. (A) An IkB-centric diagram of NFkB regulation. IkB is transcribed in an NFkB-dependent
and -independent manner. Translated IkB may bind to IKK (cyan), NFkB (yellow), or both (green), or it may shuttle to the nucleus and bind to NFkB
there. Degradation of IkB is possible from any state, though only when bound to IKK can degradation be enhanced by IKK activity. Activation of NFkB
is achieved by the time-dependent numerical inputs T (magenta) and U (violet). T represents the activity of IKK kinase while U is the efficiency of
mRNA translation. Both are defined over the interval 0,1½ , with T tƒ0ð Þ~0:01 and U tƒ0ð Þ~1:0 being their wildtype, unstimulated values. (B) The
futile (red) and productive (blue) IkB degradation fluxes. The fraction of total IkB flux through each reaction is listed next to the corresponding
reaction arrow. (C) Two stimuli used in our analysis of NFkB activation and the effects of IkB flux. Stimulation by TNF is modeled using the time-
dependent IKK activation profile described in [29] and results in strong but transient activation of NFkB. Stimulation by UV is modeled as a 50%
reduction of translational efficiency, as described in [13], and results in modest but sustained activation. As with p53, we define AT and AU to be the
maximum activity of NFkB in response to TNF and UV, respectfully, and TT to be the time at which AT is observed. Because AU is observed infinitely
often, we define TU to be the time at which NFkB activation reaches one-half AU .
doi:10.1371/journal.pcbi.1002932.g005
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considering all isostatic perturbations, some measure of the dynamic
plasticity of a system can be estimated, perhaps as a function of its
steady-state. Such an investigation can inform diagnosis of
biological samples, and whether information from a single, static
observation is sufficient to predict the response to a particular
chemical treatment, or whether live-cell measurements are required
as well. As we have shown that protein turnover can be a powerful
determinant of stimulus-sensitivity, we anticipate that kinetic
measurements will be useful predictors of sensitivity to chemical
therapeutics.
Methods
Modeling isostatic perturbations in protein turnover
To begin, we assume that the system of interest has been
modeled using mass action kinetics and that the steady state
abundance of every biochemical species is a known function of
input parameters. In other words,
x~f pð Þ
such that
dx
dt
~0: ð1Þ
Equation 1 is the well-known steady-state equation; p is a vector
of independent parameters and x is the vector of species
abundances. We use an overbar to denote a vector x that satisfies
Equation 1. For excellent reviews on mass action models and their
limitations, see [81–83]. For a method on finding analytical
solutions to the steady state equation, see our accompanying
manuscript. Next, we wish to find a change Dp in the input
parameters such that the resulting change Dx in the species
abundances is zero, where Dx is defined as
Dx~x pzDpð Þ{x pð Þ
Thus for Dx~0, we require that
x pð Þ~x pzDpð Þ:
Figure 6. Effects of IkB flux on the NFkB response to stimulation. (A) The productive flux of IkB was varied between 10{2 and 10z1 times its
wildtype value prior to stimulation by TNF (light gray to dark gray), and the resulting NFkB response values AT and TT plotted in columns 2 and 3.
Representative nuclear NFkB profiles for low, moderate, wildtype, and high values of the flux multiplier are shown at right. Again, the wildtype
productive flux is indicated by the dashed line in red. (B) The futile flux of IkB was varied between 10{2 and 10z1 times its wildtype value prior to
stimulation by TNF and the resulting NFkB response values AT and TT plotted in columns 2 and 3. (C) and (D) As rows 1 and 2, above, but the
response to UV stimulation is plotted instead of TNF.
doi:10.1371/journal.pcbi.1002932.g006
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The right-hand side of this equation can be approximated by a
truncated Taylor series, as follows:
x pzDpð Þ&x pð ÞzJxDp,
where Jx is the Jacobian matrix whose elements are the partial
derivatives of each species with respect to each parameter. Thus,
for Dx~0 we require that
JxDp~0:
In other words, Dp must lie in the null space of Jx. We call this
the isostatic subspace of the model – parameter perturbations in this
subspace will not affect any of the steady-state species abundances.
If Dp lies within the isostatic subspace, it is an isostatic perturbation
vector. Let Nx be a matrix whose columns form a basis for the
isostatic subspace. Then a general expression for an isostatic
perturbation vector is simply
Dp~Nxq, ð2Þ
where q is a vector of unknown basis vector coefficients. Finally,
Equation 2 can be solved for a specific linear combination of basis
vectors that achieves the desired perturbation. In our case we
identified those combinations that result in changes to protein
turnover.
A prototypical negative feedback model
Our prototypical negative feedback model consists of two
species, an activator ‘‘X’’ and an inhibitor ‘‘Y’’, and four reactions,
illustrated in Figure 1A. Let X denote the abundance of the
activator and Y denote the abundance of the inhibitor. An
analytical expression for the steady-state of this model was
identified by solving Equation 1 for the rates of synthesis, giving
k1~k3XY ð3Þ
k2~k4
Y
X
: ð4Þ
To parameterize the model we first let X~Y~1 a:u.
Degradation rate constants were then calculated such that
A~10 a:u: at time T~24, where again A is the maximum
amplitude of the response. Activation was achieved by instanta-
neous reduction of Y to 0. To modify the flux, we defined flux
multipliers hX and hY such that k’3~hXk3 and k’4~hYk4. Note
that by virtue of Equations 3 and 4, values for hX and hY other
than 1 result in commensurate changes in k1 and k2 such that
steady state is preserved. See file ‘‘pnfm.sci’’ in Protocol S1 for
details. Figures 2A and 2B were achieved by letting hX and hY
vary over the interval 10{1,10z1
 
, then calculating the altered
vector of rate constants k’ and simulating the model’s response to
stimulation. Figure 2C required letting hX vary over this same
interval while having hX~hY . Finally, Figure 2D was achieved by
letting hY vary over the same interval, and for each value of hY ,
numerically calculating the value of hX that gave T~24.
A model of p53 oscillations
All species, reactions, and rate equations required by our model
of p53 oscillations are as previously described [17]. Our only modifi-
cation was to scale the parameter values so that the rates of p53
Figure 7. IkB flux controls the sensitivity of NFkB to stimulation
by TNF and UV. (A) The futile flux of IkB was varied between 10{2
and 10z1 times its wildtype value prior to stimulation with variable
doses of TNF (see Methods). For low, medium, high, and wildtype
values of the futile flux, the area under the NFkB activation curve is
plotted as a function of TNF dose. The region of the plot corresponding
to low doses of TNF, where the activation of IKK does not exceed 10%,
is shaded in pink. (B) As above, but variable doses of UV are used
instead of TNF. Because the response to UV is sustained and not
transient, we have plotted the value of AU as a function of UV dose
instead of the area under the NFkB activation curve.
doi:10.1371/journal.pcbi.1002932.g007
Figure 8. A paired positive (+) and negative (2) flux motif
controls stimulus-sensitivity in the p53 and NFkB stress
response pathways. (A) For p53, the (+) flux is formed by the
synthesis and degradation of p53 itself. The (2) flux is formed by
synthesis and degradation of Mdm2. Together these fluxes control the
sensitivity of p53 to IR-stimulation, which acts by inducing the synthesis
of p53 and the degradation of Mdm2. (B) For NFkB, the (+) flux is
formed by association and dissociation of NFkB from its negative
regulator, IkB. The (2) flux is formed by synthesis and degradation of
IkB. These fluxes control the sensitivity of NFkB to TNF-stimulation,
which induces the dissociation of NFkB from IkB, and UV-stimulation,
which inhibits the synthesis of IkB.
doi:10.1371/journal.pcbi.1002932.g008
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and Mdm2 synthesis and degradation, as well as their steady-state
abundances, matched published observations (see Table S1).
Specifically we let
1 Cs~5|104 molecules, and
1 hour(Batchelor et al:)~1:33 hours:
To derive a steady-state solution for this model, we solved
Equation 1 for the steady-state abundance of Mdm2 and the rate
of Mdm2-independent p53 degradation, giving
k1~
k9
P
{
k5k10
k2
, and
M~
k10
k2
:
To simulate the response to ionizing radiation we used the
(scaled) stimulus given in [17]. Namely, at time t~0 we let the rate
of Signal production, k11, go to 5|10
5 molecules hour{1. This
stimulus was either maintained indefinitely (Figure 4A–C) or for
just 2 hours, followed by 22 hours of rest, followed by a second
2 hour stimulation (Figure 4D–F). Changes in p53 or Mdm2 flux
were achieved as above, by defining modifiers hP and hM such that
k’9~k5PM hP{1ð Þ, ð5Þ
k’2~hMk2, and ð6Þ
k’10~hMk10: ð7Þ
Prior to stimulation, we let one modifier take values on the
interval 10{2,10z1
 
while holding the other modifier constant.
Equations 6 and 7 ensure that the p53-independent flux of Mdm2
is modified without affecting its steady-state abundance. Equation
5, which is slightly more complicated, results in changes to the rate
of Mdm2-independent p53 degradation, k1, by modifying the
independent parameter k9, which controls the rate of p53
synthesis. This yields the desired
k’1~hPk1:
Numerical integration was carried out to time t~384 hours. After
each integration, we definedA? to be the minimum vertical distance
between any adjacent peak and trough in phosphorylated p53, and
A1 and A2 to be the amplitudes of the first and second peak,
respectively. Details of this model can be found in the file ‘‘p53b.sci’’
in Protocol S1. For more information on the time delay parameters ti
and tm, and their role in generating oscillations, see [84,85].
A model of NFkB activation
Our model of NFkB activation is similar to the one described in
[13], except the beta and epsilon isoforms of IkB have been
removed. Our model has 10 species and 26 reactions, the majority
of which are illustrated in Figure 5A. Rate equations and
parameter values are identical to those in [13]. An analytical
expression for the steady-state of this model was found by solving
Equation 1 for the following dependent variables: I , IK , INK , In,
and IN, and the rate constants k11, k16, and k19. The precise
expressions for these variables are extremely cumbersome but may
be found in their entirety in the file ‘‘nfkb.sci’’ in Protocol S1.
Activation of NFkB is achieved by either of two, time-
dependent numerical input variables, T and U . T modifies the
activity of IKK while U modifies the efficiency of IkB translation.
Both have a finite range of 0,1½  and have unstimulated, wildtype
values of T~0:01 and U~1:0, respectively. The inflammatory
stimulus TNF is modeled using a unique function of T derived
from in vitro kinase assays [30]. Since these assays only measured
IKK activity out to 4 hours, we extended each stimulus by
assuming the value of T at 4 hours is maintained out to 24 hours.
Justification for this can be found in the 24-hour kinase assays in
[86], which shows no IKK activity between 8 and 24 hours after
TNF stimulation. UV stimulation is modeled using a step decrease
in the value of U from 1.0 to 0.5 for the entire 24 hours. This
mimics the 50% reduction in translational efficiency observed in
[13].
Steady-state analysis of this model revealed that over 99% of all
IkB was degraded via either of two pathways, futile (92%) and
productive (7%). See Figure 5B for the composition of these
pathways. To modify the flux through either pathway without
altering any of the steady-state abundances, the algebraic method
described above proved absolutely necessary. Specifically, we
solved Equation 2 for the unique set of basis vector coefficients
such that the following conditions held: (1) only reaction rate
constants involved in the targeted pathway were modified; (2) if a
reaction on the pathway was reversible, its ratio of forward to
reverse rate constants was preserved; and (3) the magnitude of an
alteration was relative to the bottleneck reaction. For the futile flux
this was k26, the degradation of unbound nuclear IkB. For the
productive flux it was k6, the export of NFkB-bound IkB. As in the
p53 models above, we then defined multipliers hF and hP such that
k’26~hFk26
k’6~hPk6:
See file ‘‘nfkb.sci’’ in Protocol S1 for the precise effect of hF and
hP on the other rate constants in the model. Finally, to generate
Figure 6 we let the appropriate multiplier take values on the
interval 10{2,10z1
 
prior to stimulation with TNF or UV.
Dose response curves in Figure 7 were generated by letting hF
take values in 10{2,10{1,100,10z1
 
and simulating the response
to varying doses of TNF or UV. To vary the TNF dose, we scaled
the displacement of the numerical IKK activation curve above its
basal value of 1% using log-spaced multipliers on the interval
10{2,100
 
. We call this multiplier the ‘‘stimulus strength’’. A
stimulus strength of 10{1:0, for example, yields the same basal
IKK activity as the full TNF dose used in Figure 6, but a peak
activity whose magnitude is just one-tenth that of the full dose. To
measure the TNF response, we calculated an area under the curve
(AUC) by subtracting NFkB basal activity from the TNF-induced
NFkB activation curve, then integrated this curve from the point
of stimulus to the time at which it becomes less than one-tenth the
basal activity. All AUCs were normalized to the full TNF dose. To
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vary the UV dose we varied the magnitude of the displacement of
U from unity. A stimulus strength of 0.1, for example, results in a
step decrease in U from 1.0 to 0.9. Because the response to UV is
sustained instead of transient, we plotted AU as a function of
stimulus strength instead of the area under the curve.
Supporting Information
Figure S1 Locations of Mdm2, p53, and IkBa in a
genome-wide distribution of protein flux. A histogram of
protein flux was generated from data in [4] N~5030ð Þ. Assuming
first-order degradation kinetics, the published half-life for each
protein was used in conjunction with its steady-state abundance to
calculate its rate of synthesis. This rate was then divided by the
steady-state abundance to derive each protein’s normalized flux, that
is, the fraction of its steady-state population that is synthesized
every hour. Normalized flux values for Mdm2, p53, and unbound
IkBa are indicated by the dashed lines. Daggers denote proteins
whose half-lives are extrinsic to the dataset.
(TIF)
Figure S2 Choice of interval time does not affect the
role of Mdm2 flux in p53 refractory time. This plot is
identical to Figure 4D–E, except that the interval between pulses is
taken to be 6 (magenta), 12 (yellow), 24 (green), or 48 hours (cyan).
Representative traces at right are grouped according to interval
time.
(TIFF)
Protocol S1 Executable source code. This zip file contains
executable code for all three models discussed in the manuscript.
All code can be executed using the freely available Scilab
numerical computing environment, http://www.scilab.org/. See
the included README file for detailed instructions.
(ZIP)
Table S1 Parameter values used to simulate the model
of p53 oscillations. This table lists all parameters required to
simulate the model of p53 oscillations. Parameters with published
values are shown for comparison.
(DOCX)
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